News
In its first set of financial figures since spinning off its consumer health division, GSK has reported a 19% increase in revenues, driven by burgeoning demand for its shingles vaccine Shingrix ...
Analysts at Evalute Pharma puts Shingrix as the most valuable vaccine candidate in the industry's pipelines, forecasting sales of $1.12 billion by 2022. Skip to main content Monday 23 June 2025 ...
Q. I started having diarrhea in April of 2024. I had it every day (10 to 15 times) for the next 12 months and lost 60 pounds. All tests and analyses came back normal. The gastroenterologist said ...
Shingrix, now recommended for adults older than 50, is 90% effective in preventing shingles and the lingering nerve pain that can result. In 2021, however, only 41% of older Americans had received ...
I received the Shingrix vaccine. When I get an occasional cold sore, I take acyclovir. For prevention, I take L-lysine daily. Has this been studied as a prevention against Alzheimer disease?
In the United States, where a more potent vaccine, Shingrix, became available in 2017 and supplanted Zostavax, Oxford investigators found an even stronger effect. By matching almost 104,000 older ...
Shingrix, now recommended for adults over 50, is 90% effective in preventing shingles and the lingering nerve pain that can result. In 2021, however, only 41% of adults 60 and older had received ...
In the United States, where a more potent vaccine, Shingrix, became available in 2017 and supplanted Zostavax, Oxford investigators found an even stronger effect. By matching almost 104,000 older ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results